Loading...
XLON
ANCR
Market cap228mUSD
Dec 05, Last price  
248.10GBP
1D
-0.36%
1Q
-2.32%
Jan 2017
-17.30%
IPO
331.48%
Name

Animalcare Group PLC

Chart & Performance

D1W1MN
XLON:ANCR chart
P/E
5.31
P/S
2.31
EPS
0.47
Div Yield, %
2.02%
Shrs. gr., 5y
0.55%
Rev. gr., 5y
0.86%
Revenues
74m
-0.17%
7,852,0008,301,00011,755,00017,638,00011,223,00011,825,00010,856,00012,118,00012,881,00013,536,00014,701,00015,867,00062,291,00072,470,00071,124,00070,494,00074,024,00071,616,00074,351,00074,228,000
Net income
32m
+2,586.99%
203,000250,000893,0001,039,000-1,031,0002,325,0001,729,0001,885,0002,137,0002,534,0002,634,0002,470,000184,000-222,000-1,338,000234,000-77,0001,965,0001,199,00032,217,000
CFO
12m
+16.07%
646,000984,0001,435,0002,433,0001,936,0002,145,0002,123,0002,831,0001,067,0003,892,0004,136,0002,421,0001,897,0007,430,00013,106,00011,117,00014,023,0009,429,00010,281,00011,933,000
Dividend
Oct 17, 20242 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets. It is also involved in the wholesale and marketing of veterinary pharmaceuticals. The company serves customers in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, other European countries, Asia, the Middle East, Africa, and internationally. Animalcare Group plc was incorporated in 1972 and is based in York, the United Kingdom.
IPO date
Jan 15, 2008
Employees
220
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT